1/1
2 files

Supplementary Tables – Attitudes towards pharmacogenetics in patients undergoing CYP2C19 testing following percutaneous coronary intervention

dataset
posted on 11.01.2022, 14:36 by Figshare Future Science GroupFigshare Future Science Group, Grace Lee, Lisa A. Varughese, Laura Conway, Carol Stojinski, Sandhya Ashokkumar, Karen Monono, William Matthai, Daniel M. Kolansky, Jay Giri, Sony Tuteja

Supplemental Table 1: Average Participant Responses to Questions Assessing Attitudes Toward PGx Testing on a Scale of 1 (Strongly Disagree) to 5 (Strongly Agree)

Supplemental Table 2: Average Participant Responses to Questions Assessing Ethics of PGx Testing on a Scale of 1 (Strongly Disagree) to 5 (Strongly Agree)

Funding

National Heart Lung Blood Institute K23HL143161

National Center for Advancing Translational Sciences TL1TR001880

History